US Capital Partners has provided a $750,000 growth capital term loan for Advanced Health Sciences, Inc. (“AHS”), headquartered in West Palm Beach, FL.

“We are delighted that US Capital Partners has successfully provided this growth capital financing for us,” said Jeff Ramey, founder and CEO of AHS. “We returned to US Capital Partners following the successful financing of our sister company, Ramard, Inc. This new growth capital financing will allow AHS to offer a range of new cutting-edge natural health care products, including a varicose vein product, a migraine product, a respiratory product for sufferers of asthma and chronic obstructive pulmonary disease, and a digestive product to battle Celiac disease, Crohn’s disease, and diverticulitis.”

“In December 2012, US Capital Partners successfully provided an accounts receivable and inventory line of credit scalable to $1 million for AHS’s sister company, Ramard, Inc., an expanding developer of high-quality equine and canine nutraceutical health care products,” said Jeffrey Sweeney, CEO and managing director at US Capital Partners. “Ramard’s products are used by nine Olympics equestrian teams around the world, as well as top Kentucky Derby Thoroughbreds. We are delighted now to have provided $750,000 in additional financing for the group.”

AHS is a collaboration of experienced health care professionals and scientific specialists who are dedicated to developing innovative, next-generation products for specific targeted health concerns.

Since 1998, US Capital Partners has been providing prompt, innovative, and reliable financing solutions including lending, equity financing, and debt re-structuring to businesses across the United States and abroad.